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38 states. Using the data-analysis software SAS Enterprise Guide, the data were ana-
lyzed for signiﬁ cant variables by comparing a treatment and control group through 
frequencies, densities, summary statistics, logistic regression, and linear regression
models. RESULTS: Initial analyses reveal the majority of infants diagnosed with peri-
natal infection are male. There is a higher occurrence of the disease in hispanic and
black infants and lower occurrence in whites. The disease is life-threatening and is
linked to a longer length of stay and higher total charges. Regression models showed
that there are inversely and directly proportional relationships between disease
presence and a variety of diagnoses and procedures, some of which can signiﬁ cantly 
increase a patient’s length of stay and total charges. CONCLUSIONS: Patient descrip-
tors such as race and gender can affect the presence of perinatal infection, and certain
common additional diagnoses and procedures associated with the disease can signiﬁ -
cantly prolong a patient’s length of stay and increase total charges. Applying these 
results to perinatal infection research, there should be more focus on these factors in
order to improve the efﬁ ciency and quality of perinatal infection treatment and 
management.
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OBJECTIVES: Premenstrual symptoms can interfere in a woman’s life in many areas,
including sexual desire. This study objective was to evaluate characteristics of 
women with premenstrual syndrome (PMS) and their impact on sexual drive. 
METHODS: Data were collected through an online survey study of adult females age
18–45, who were sexually active in the past three months and experienced some pre-
menstrual complaints such as irritability, depression, headache and abdominal bloat-
ing. Participants completed the following questionnaires: Sexual Function Questionnaire
– desire component (SFQ-D), Premenstrual Symptoms Impact Survey (PMSIS), and 
SF-12v2 Health Survey. The retrospective criteria of the American College of Obstetri-
cians and Gynecologists were used to determine presence or absence of PMS. Logistic
regression was used to assess the association between sexual desire dysfunction and 
the following factors: presence of PMS, current age, age at ﬁ rst menstruation, race, 
employment status, current and past use of oral contraception, and presence of any 
chronic condition. RESULTS: A total of 671 women (mean age  30.8) were included
for analyses. Based on the SFQ-D, 35.3% of women were identiﬁ ed as having high
probability of sexual desire dysfunction. T-test demonstrated signiﬁ cant score differ-
ences between women with and without sexual dysfunction both for the SF-12 mental 
component summary score and the PMSIS score. Logistic regression showed that
age (p  0.037) and presence of PMS (p  0.024) were associated with a higher 
risk of sexual desire dysfunction while current use of oral contraception reduced the 
risk (p  0.009). CONCLUSIONS: This study shows that a substantial number of 
women with PMS likely experience sexual drive dysfunction. Probability of experienc-
ing sexual desire dysfunction increases with age and presence of PMS, while current 
use of oral contraception use appears to mitigate the impact of sexual desire
dysfunction.
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OBJECTIVES: Premenstrual Syndrome (PMS) and Premenstrual Dysphroric Disorder 
(PMDD) can have signiﬁ cant impact on women’s work productivity. This study objec-
tive was to assess the degree of productivity impairment associated with PMS and
PMDD. METHODS: Data were collected through an online survey of adult employed 
females aged 18–45 years (N  634), with some premenstrual complaints such as 
irritability, depression, headache, and abdominal bloating. Responses from the Work
Productivity and Activity Impairment Questionnaire (WPAI) and the Work Limitations 
Questionnaire (WLQ) and its subscales (Time Management, Physical, Mental/Inter-
personal and Output) were analyzed. The retrospective criteria of the American 
College of Obstetricians and Gynecologists and the DSM-IV-TR were used to identify 
women with Premenstrual Syndrome (PMS) and Premenstrual Dysphoric Disorder 
(PMDD) respectively. The study controlled for age using multivariate ANOVA and
compared the following groups: 1) women that did not meet criteria for PMS or
PMDD (66.4%); 2) women that met the criteria for PMS but not PMDD (18.9%); 
and 3) women that met the criteria for PMDD (14.7%). RESULTS: Multivariate 
ANOVA showed signiﬁ cant differences across the three groups for the composite 
Productivity Loss of the WLQ and its subscales as well as for the WPAI (all p  0.001). 
When compared to women without PMDD or PMS, the model estimated greater work 
impairment scores for the PMDD group than for the PMS group. Post-hoc analysis 
revealed signiﬁ cant differences in scores between all groups for all outcomes (p  0.05) 
except between PMS and PMDD groups for the WLQ-Time Management and PMS 
and non-PMS/PMDD groups for the WLQ-Physical. CONCLUSIONS: Presence of 
PMS and PMDD substantially impairs women’s work productivity.
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OBJECTIVES: Very few studies have tried to evaluate comparative physician satisfac-
tion across specialties and non specialties. We examined the differences in physician 
satisfaction achieved and the total care obtained by patients from different caregivers 
in the health care system like obstetricians and gynecologists, primary practitioners
and other specialty physicians. METHODS: We conducted a cross sectional and
national web based survey study consisting of anonymous patients who rated their 
physicians on the basis of treatment satisfaction that they received from their most 
recent outpatient visits. The survey was user friendly, validated and helped patients
identify their physicians as per specialties and rate them on a scale of 0 (“not at all
satisﬁ ed”) to 10 (“extremely satisﬁ ed”). The association between physician satisfac-
tion and patient rating of total care among obstetricians and gynecologists, other 
specialists and primary practitioners was assessed using ordered logistic regression. 
RESULTS: A total of 35,512 patients who rated physicians belonging to the categories
of obstetricians and gynecologists (14%), primary practitioners (50%) and other spe-
cialties (36%) were included in the study. After controlling other variables, the log
odds of patient rating of total care for non-specialty physicians were 0.26 less in value 
that those for obstetricians and gynecologists (p  0.001). Other things being equal, 
the log odds of patient satisfaction for specialty physicians were 0.17 higher in value 
than those for obstetricians and gynecologists (p  0.001). After controlling for other
variables, the log odds of patient satisfaction for non-specialty physicians were 0.15 
less in value than those for obstetricians and gynecologists (p  0.001). CONCLU-
SIONS: Patient rating of total care was strongly associated with obstetricians and 
gynecologists compared to other specialty physicians and primary practitioners. The
patient satisfaction ratings in obstetricians and gynecologists were higher compared
to primary practitioners and lower compared to other specialists.
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OBJECTIVES: The objective of this study is to determine whether spouses with work 
disability in dual-earner families are at an increased risk for retirement and how the 
risk varies among different conditions. METHODS: The study uses eight biennial
waves (1992–2006) of the Health and Retirement Study (HRS), a nationally represen-
tative panel survey of the U.S. population over age 50. The ﬁ nal sample includes 3199 
couples in which both a husband and a wife were in the labor force and did not
mention being retired at the ﬁ rst interview. Retirement is deﬁ ned as a departure from
the labor force. Work disability (whether health limits amount or kind of work) and 
retirement are linked to the chronological date (month and year are available in the
data). Separate Cox proportional hazards models estimate hazards of wives’ and hus-
bands’ retirement as a function of own health and other confounding factors. The
analysis start date is a wife’s (a husband’s) 50th birthday or the date of the ﬁ rst inter-
view, whichever comes last. RESULTS: Work disability is associated with much higher
risk of retirement. Wives with work limitations have a 2.23 times higher hazard of 
retirement (HR 2.23 [95% CI, 1.98–2.50]) than do wives without a work disability. 
The onset of own work disability raises the conditional probability of husbands’ 
retirement by 2.7 times (HR 2.70 [95% CI, 2.42–3.02]). Health conditions that caused
work disability and associated with the highest risk of retirement for wives are: heart, 
cancers, and respiratory, in that order. For husbands similar conditions are: emotional 
and psychological, cancers, and heart. CONCLUSIONS: Work disability prevention 
can decrease loss of productivity related to earlier retirement. Identifying best-practice
disease prevention and health promotion programs through evidence-based research
will help government, employers, health plans and workers to decrease the risk of 
developing a disabling condition.
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ACROSS SEVERAL DISEASES: BIPOLAR DISORDER, OTHER MENTAL
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OBJECTIVES: To compare the at-work productivity (presenteeism) among employees
with bipolar disorder (BPD), other mental disorders (OMD), chronic constipation 
(CC), functional dyspepsia (FD), gastroesophageal reﬂ ux disease (GERD), gout, and 
insomnia. BACKGROUND Medical conditions impact employee productivity in dif-
fering ways. Little is known on the productivity of persons using objectively measured 
data. Self-assessed productivity impairments are not always validated with objective 
measures. METHODS: A 2001–2007 US employee database was used to identify 
subjects with BPD, OMD, CC, FD, GERD, gout, and insomnia (based on medical
claim ICD9s) using objective electronically collected productivity data for employees
in task-oriented positions. All studies used regression models to control for demo-
graphic differences between subjects with the condition and control groups of subjects 
without the condition. For all subjects (by study), the controls used the average index 
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date of the subjects with the disease. Hourly productivity was units produced per hour
worked during the year. Annual productivity was total units produced during the year.
Incremental productivity  adjusted differences between the disease cohort and the 
controls and considered signiﬁ cant at P a 0.05. RESULTS: Employees with productiv-
ity eligibility for the disease/controls were: BPD 59/27,574; OMD 1,382/25,268; CC 
82/27,276; FD 73/27,513; GERD 541/26,775; gout 86/27,472; and insomnia
415/26,240. Hourly productivity results (incremental units per hour worked; percent
disease/control; signiﬁ cance) were: CC (1.26; 106.6%; P  0.05); insomnia (0.46;
102.5%; P  0.05), OMD (0.41; 102.0% P  0.05), GERD (0.849; 95.6%; P 
0.0481), gout (0.65; 96.5%; P  0.05), BPD (1.35; 93.5%; P  0.05); and FD (1.73;
90.8%; P  0.05). Annual productivity results (incremental units per year; percent 
disease/control; signiﬁ cance) were: GERD (1754; 94%; P  0.0391), OMD (414; 
101.2%; P  0.05); CC (194; 100.7%; P  0.05); gout (566; 98.0%; P  0.05), 
insomnia (925; 96.8%; P  0.05), FD (3,022; 89.1%; P  0.05); and BPD (7,103; 
79.9%; P  0.0001). CONCLUSIONS: Employees with GERD have signiﬁ cant
decreases in both annual and hourly productivity. Employees with BPD experienced
a signiﬁ cant decrease in annual productivity but not in hourly productivity. Many
comparisons were not signiﬁ cant, which contradicts some self reported data indicating
impairment due to the conditions.
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OBJECTIVES: The productivity costs of intimate partner violence (IPV) have received
considerable attention by human resource experts, employers and news outlets, includ-
ing the BBC and Washington Post. Absences, tardiness and turnover have been esti-
mated. Yet, validated estimates of “presenteeism” (functioning at work) are unknown. 
METHODS: In 2007, 190 female IPV victims petitioning a US court for orders for 
protection (OP) consented to participate in a randomized control trial which included 
the validated Work Limitations Questionnaire, the SF-12v2, the CES-D (for depression
and anxiety), the CTS2S and the Danger Assessment. The WLQ is sensitive to changes
in depression and anxiety over time and to a variety of medical and behavioral health 
conditions. We report descriptive statistics and univariate comparisons of working and 
non-working subjects using the WLQ. The paper will include multivariate analyses 
controlling for mental health and overall health status, neighborhood poverty rates 
and household characteristics, and comparisons among scales of speciﬁ c domains 
(time management, mental/social performance, physical, output). The sample is com-
prised of 122 subjects who completed time two assessments. RESULTS: Employed 
subjects report a mean WLQ Productivity Loss Score of 94.3 (range 75.13–100; s.d. 
6.28), representing a performance loss while working, of 5.7% (or 4.6 hours over 2
weeks of full-time employment) compared to the healthy worker norm. Employed
women (n  75) reported better health, less danger, and less severe mental health 
symptoms than those outside of the workforce (n  47) at the time of their OP Peti-
tions. CONCLUSIONS: To our knowledge, these are the ﬁ rst estimates of work loss
reported by IPV victims. When considered on a continuum of burden of illness due
to work productivity loss, preliminary data suggest this population has a greater 
burden of illness than breast cancer survivors, but a lower burden than employees
with active major clinical depression.
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THE IMPACT OF MEDICARE PART D ON HEALTH CARE UTILIZATION
AND HEALTH OUTCOMES FOR MEDICARE BENEFICIARIES WITHOUT 
PREVIOUS DRUG COVERAGE
LIU/Mr XQ, Walton SM, Crawford SY, Pickard AS
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OBJECTIVES: To examine, using nationally representative data, the impact of Medi-
care Part D on medication utilization, out-of-pocket-costs, non-drug medical service 
utilization, and health outcomes among civilian non-institutionalized Medicare beneﬁ -
ciaries without prescription drug coverage prior to the implementation of Medicare 
Part D. METHODS: The primary data were from the Medical Expenditure Panel 
Survey (MEPS) panel 10 data and the corresponding 2005 and 2006 pharmacy com-
ponent data. This study included Medicare beneﬁ ciaries between 65 and 79 years old 
that had only Medicare Fee for Service (FFS) in 2005. Patients between 55 and 63 
years old with no drug coverage in 2005 served as control subjects. Difference-in-dif-
ferences was used to identify the effects of Medicare Part D on health care utilization,
expenditures, non-drug medical service utilization, and health outcomes among Medi-
care beneﬁ ciaries. RESULTS: The mean amount paid by the near elderly without 
insurance in 2005 declined 7.8%, while the mean amount paid by Medicare beneﬁ -
ciaries with Medicare FFS only in 2005 decreased 40.6%. The number of prescription 
reﬁ lls of the near elderly increased 10.35%, while there was only 4.3% increase among
the Medicare beneﬁ ciaries. ER visits among the Medicare FFS group declined 2.6%, 
while the number of ER visits among the near elderly increased 0.94%. There was 
only small growth rate difference in other outcomes variable. CONCLUSIONS: Evi-
dence from the MEPS data set suggests that Medicare Part D reduced out of pocket 
costs, drug utilization, and ER visits among patients without prior coverage. While 
cost reduction was expected, the reduction in utilization of drugs was not. Future 
research should further examine these trends.
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THERAPY IN AN INSURED POPULATION WITH A STATE FERTILITY
MANDATE
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OBJECTIVES: To estimate the proportion of all very-low and moderately-low-birth-
weight (VLBW, MLBW) infants and the short-term costs associated with fertility 
therapy in an insured population with a state mandate that requires coverage for fertil-
ity drugs but not in vitro fertilization (IVF) or drugs used with IVF. METHODS: The 
study sample consists of all live births, 2003–2007, that could be linked to mothers
with continuous pharmacy and medical beneﬁ ts eligibility during the 11 months before
delivery, within a geographically deﬁ ned subset of a commercially insured population. 
Likely causal relationships with fertility therapy are deduced and categorized as clo-
miphene or follicle-stimulating hormone (FSH) / intrauterine insemination (IUI) or 
IVF, based on the intervals between the dates of delivery and claims for IUI, clomi-
phene, FSH, or embryo transfer. Birthweight is categorized from claims coding. Mater-
nal and infant claims charge distributions are characterized. RESULTS: Of 31,708 live 
births from 30,905 deliveries by 27,195 distinct women, clomiphene, FSH, and FSH 
 IVF categories respectively account for 4.2%, 2.8%, 0.7% of the total number;
8.9%, 16.4%, 3.9% of all VLBW; 8.7%, 12.1%, 3.5% of all MLBW. Mean infant
charges during the 12 months after birth were not signiﬁ cantly different from other 
infants in the same birthweight categories. Mean charges during ﬁ rst 12 months for
all VLBW, MLBW, and other infants were, respectively, $248,600, $33,560, $6,990, 
and low-birthweight infants collectively accounted for 41.6% of all claims charges
for infants. Differences in mean maternal charges are explained by fertility therapy, 
Caesarian section, and multiple gestation. CONCLUSIONS: Analysis of administra-
tive claims data can supplement IVF registry data and published single or multicenter
studies to inform models that predict outcomes and costs associated with different 
policy choices.
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OBJECTIVES: Japanese version of Beers criteria (JP-BC) for potentially inappropriate 
medications in elderly patients was developed by consensus among nine specialists in
order to reﬂ ect regional medical practice and available medications. The prevalence of, 
and risk factors and medical costs associated with JP-BC were examined. METHODS:
A cross-sectional study was conducted using health insurance claims data in Japan. 
Patients aged 65 years or older and had a pharmacy claim between October 2006 and
September 2007 were selected and the use of JP-BC was identiﬁ ed. Associations with
patient demographics, health care utilization patterns and co-morbidities were assessed 
using logistic regression models. Medical costs associated with the JP-BC were also
examined using generalized linear models. RESULTS: Among 6991 old patients, 
41.2% were used one of the JP-BC. Commonly used medications were H2 blockers
(19.5%), benzodiazepines (10.9%) and anticholinergics and antihistamines (7.8%).
Patients with multiple medications, long-term inpatient care and multiple chronic
conditions including gastrointestinal and cardiovascular diseases were more likely to 
use JP-BC. Mean annual cost for JP-BC users was 517,516 yen (5,625 US$), which 
was 2.4 times higher than that in non JP-BC users. Cost differences were still observed
after risk adjustment using Charlson or Elixhauser co-morbidities. High medical costs 
among JP-BC users were partly explained by their high likelihood of multiple medica-
tions and long-term inpatient care. CONCLUSIONS: The prevalence of potentially 
inappropriate medication use in Japan was relatively higher than those previously 
reported in other countries even though regional speciﬁ c medications were considered. 
Drug utilization reviews using the criteria must be promoted to increase awareness of 
inappropriate pharmaceutical cares among elderly and control medical costs.
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OBJECTIVES: The Medicare Part D prescription drug beneﬁ t was introduced for 
Medicare enrollees to obtain prescription drug coverage. The 2006 beneﬁ t did not
provide insurance coverage for standard prescription drug plan (PDP) members who 
incurred prescription costs between $2250 and $3600 dollars (referred to as the 
“doughnut hole”). We evaluated whether the “doughnut hole” was a factor in altering
the prescription fulﬁ llment decisions of Part D members. METHODS: In the current 
retrospective cohort study, 750 pharmacy adjudication records from a national Part
D HMO pharmacy database were investigated for the year 2006. Five hundred par-
ticipants (standard PDP members) without coverage in the doughnut hole were com-
pared to a group of 250 participants (enhanced PDP members) whose prescription
coverage did not lapse in the doughnut hole. All participants were analyzed via a 
multivariate strategy for their prescription fulﬁ llment decisions which were recorded
as an endpoint of ﬁ lling, delaying, switching, or stopping their respective medication. 
RESULTS: From 72% of the standard PDP members who experienced the doughnut 
hole and altered their prescription decision, it was determined that 22% delayed
